JPH Stock Overview
Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Jerusalem Pharmaceuticals Co. Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.81 |
| 52 Week High | US$4.01 |
| 52 Week Low | US$3.50 |
| Beta | 0.15 |
| 1 Month Change | 0.26% |
| 3 Month Change | 0.26% |
| 1 Year Change | -5.69% |
| 3 Year Change | 29.15% |
| 5 Year Change | 24.92% |
| Change since IPO | 209.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| JPH | PS Pharmaceuticals | PS Market | |
|---|---|---|---|
| 7D | -0.5% | 1.5% | -1.5% |
| 1Y | -5.7% | 1.5% | -17.3% |
Return vs Industry: JPH underperformed the PS Pharmaceuticals industry which returned 1.5% over the past year.
Return vs Market: JPH exceeded the PS Market which returned -17.3% over the past year.
Price Volatility
| JPH volatility | |
|---|---|
| JPH Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 3.2% |
| 10% most volatile stocks in PS Market | 5.9% |
| 10% least volatile stocks in PS Market | 2.2% |
Stable Share Price: JPH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine JPH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 543 | Mohammed Mahmoud Masrouji | www.jepharm.ps |
Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. It offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. The company produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions.
Jerusalem Pharmaceuticals Co. Ltd. Fundamentals Summary
| JPH fundamental statistics | |
|---|---|
| Market cap | US$68.58m |
| Earnings (TTM) | US$8.67m |
| Revenue (TTM) | US$43.13m |
7.9x
P/E Ratio1.6x
P/S RatioIs JPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JPH income statement (TTM) | |
|---|---|
| Revenue | US$43.13m |
| Cost of Revenue | US$19.18m |
| Gross Profit | US$23.95m |
| Other Expenses | US$15.28m |
| Earnings | US$8.67m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.48 |
| Gross Margin | 55.53% |
| Net Profit Margin | 20.11% |
| Debt/Equity Ratio | 3.0% |
How did JPH perform over the long term?
See historical performance and comparison